Menu
ncarol.com
  • Home
  • Education
  • Health
  • Technology
  • Financial
  • Business
  • Books
  • Entertainment
  • Real Estate
ncarol.com

CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
ncarol.com/10322420

Trending...
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
CIA Mind Control History
Declassified records reveal coordinated psychiatric participation in behavioral control experiments, raising urgent oversight questions as psychotropic drugs are prescribed to more than 76 million Americans.

LOS ANGELES - ncarol.com -- By CCHR International

Media outlets are increasingly reporting on the CIA's behavioral research programs of the 1950s and 1960s, which experimented with drugs and psychological techniques to influence human behavior. This renewed attention follows the 2024 release of CIA and the Behavioral Sciences: Mind Control, Drug Experiments and MKULTRA by the National Security Archive and ProQuest. The collection of more than 1,200 documents reveals how U.S. intelligence agencies and psychiatrists collaborated in programs exploring whether drugs and psychological techniques could manipulate behavior. The records describe experiments involving LSD, hypnosis, electroshock, and sensory deprivation—often conducted on unwitting individuals.[1] The Citizens Commission on Human Rights International (CCHR) began exposing these psychiatric mind control programs in the 1970s through Freedom of Information Act disclosures and by monitoring the 1975–1977 congressional hearings that investigated CIA-psychiatric experiments. The records underscore enduring ethical concerns, as critics argue the psychiatric industry continues to subject the public to large-scale behavioral experimentation without fully informed consent.

In 1954, under "Operation Artichoke," the CIA formally examined whether a person could be secretly induced to commit an assassination against his will. A January 15, 1954 CIA document discussed whether a subject could be "surreptitiously drugged through the medium of an alcoholic cocktail at a social party."[2] The objective was explicit: chemical manipulation of behavior without consent.

Declassified memoranda show this research was systematic and coordinated:
  • December 3, 1951: document stated a person could be reduced "to the vegetable level" through electroshock.
  • February 12, 1952: memo called for securing and training "super-experts" combining psychiatry, psychology, and medicine to apply electroshock, LSD, and hypnosis.
  • December 27, 1963: memo stated testing on "unwitting" subjects was the only "realistic method" for maintaining behavioral-control capabilities.
  • 1956: MKULTRA chief Sidney Gottlieb approved high-dose LSD testing on federal prisoners.
  • November 3, 1960: memo sought techniques to create durable amnesia and "indefinitely durable control for future behavior."

Psychiatrists and behavioral scientists were not peripheral advisers; they were essential architects.

More on ncarol.com
  • Colorfront Launches New Mac App For Creating Apple Immersive Video
  • Michele Mundy's "Divinely Tailored" Gains Momentum
  • Evermore Bliss Launches AI Wedding Speech Writer to Help Users Create Personalized, Heartfelt Toasts
  • Keenethics enters the ChatGPT Apps ecosystem as a new growth opportunity for businesses
  • Spring Into Your New Home at Heritage at South Brunswick

CIA-funded experimentation extended to Canada at Montreal's Allan Memorial Institute, where psychiatrist Donald Ewen Cameron directed MKUltra Subproject 68. Cameron, who served as president of the World, American, and Canadian Psychiatric Associations, used massive electroshock, prolonged drug-induced sleep, high-dose LSD, and "psychic driving" techniques that left patients cognitively damaged.[3]

In the 1950s, LSD was actively explored as a weapon. Pharmaceutical companies supplied the CIA and U.S. Army with the drug for clandestine research.[4] Hallucinogens were evaluated as tools capable of inducing panic, confusion, and psychological destabilization.[5]

Between 1949 and 1968, the U.S. Army conducted 239 open-air germ warfare tests in American cities. In June 1966, bacteria dispersal tests were conducted in the New York City subway system to evaluate how an airborne agent might spread among commuters, who were never informed.[6]

Internal CIA reviews acknowledged that MKUltra testing placed "the rights and interests of U.S. citizens in jeopardy."[7]

In 1967, a conference titled Psychotropic Drugs in the Year 2000 openly discussed the psychiatric-pharmaceutical industry's search for "chemical substances which would have mind-altering properties" and develop the potential for "nearly a total control of human emotional status, mental functioning, and will to act."[8]

In 2008, the Mitre Corporation conducted a Human Performance Study for the U.S. Department of Defense Research and Engineering Enterprise, which examined how psychoactive drugs might be weaponized by adversaries. The report warned that foreign adversaries may monitor newly approved drugs in the U.S., which would have extensive off-label use, and may exploit these compounds in training or field operations.[9]

Today, millions are prescribed psychotropic drugs, many of which carry regulatory warnings for agitation, hostility, aggression, suicidal ideation, and, in some cases, homicidal thoughts. A 2020 University of Connecticut School of Pharmacy review identified aggression and violent behavior as recognized adverse drug reactions and during withdrawal.[10]

Jan Eastgate, President of CCHR International, says: "The contradiction is stark: psychiatrists collaborated with intelligence agencies to study how drugs could adversely manipulate behavior. Today, similar classes of drugs are prescribed on a massive civilian scale. Regulators themselves acknowledge that these drugs can induce aggressive, suicidal, and even violent behavior."

More on ncarol.com
  • Justin Fairfax Dies in Apparent Murder Suicide
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • HarryPotterObamaSonic10Inu (Ticker: BITCOIN) Is the Best Cryptocurrency in Global History
  • First Flight Society Selects John and Martha King as 2026 Paul E Garber First Flight Shrine Honorees
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)

She added: "The released CIA records should not merely prompt historical reflection but compel federal authorities to confront and correct the ongoing failure to adequately monitor severe behavioral adverse drug reactions in mental health systems."

CCHR, which was established in 1969 by the Church of Scientology and professor of psychiatry, Thomas Szasz, calls for a mandate to conduct comprehensive toxicology tests for psychotropic drugs in acts of senseless violence and the establishment of a national database recording the findings, as a matter of public transparency.

Sources:

[1] National Security Archive, "CIA Mind Control Experiments Focus on New Scholarly Collection," nsarchive.gwu.edu/briefing-book/dnsa-intelligence/2024-12-23/cia-behavior-control-experiments-focus-new-scholarly

[2] Nicholas M. Horrock, "C.I.A. Documents Tell of 1954 Project to Create Involuntary Assassins," The New York Times, 9 Feb. 1978; "Declassified CIA memo reveals plan to turn citizens into unwitting assassins," Daily Mail, 27 Feb. 2026

[3] National Security Archive, "CIA Mind Control Experiments Focus on New Scholarly Collection," nsarchive.gwu.edu/briefing-book/dnsa-intelligence/2024-12-23/cia-behavior-control-experiments-focus-new-scholarly; "Declassified: Mind Control at McGill," section "The CIA seeks key to mind control," The McGill Tribune, www.thetribune.ca/mind-control-mcgill-mk-ultra/; "25 Years of Nightmares," The Washington Post, 28 July 1985

[4] Gordon Thomas, Journey into Madness: The True Story of Secret Mind Control and Medical Abuse, (Bantam Books, June 1989), p. 99

[5] Stephen Kinzer, Prisoner in Chief: Sydney Gottlieb and the CIA Search for Mind Control, (Henry, Holt & Company, 2019), p. 36

[6] Philip Messing, "Did the CIA test LSD in the New York City subway system?" New York Post, 14 Mar. 2010; U.S. Army, A Study of the Vulnerability of Subway Passengers in New York City to Covert Attack with Biological Agents, Miscellaneous Publication No. 25, Fort Detrick, MD: U.S. Army Biological Laboratories, Jan. 1968

[7] Tom O'Neill, Chaos: Charles Manson, the CIA, and the Secret History of the Sixties, (Little, Brown & Co. June 2019), pp.355-356

[8] Psychotropic Drugs In The Year 2000 Use by Normal Humans, (Springfield, Illinois, Charles C. Thomas Publisher, 1971), pp. xii, xx, xix

[9] "Human Performance", Mitre Corporation, JASON Program Office, sponsored by Office of Defense Research and Engineering, Mar. 2008

[10] "Patient Safety: Aggression, Irritability, and Violence: Drug-induced Behaviors," University of Connecticut School of Pharmacy, Feb. 2020

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights International
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Giftella Launches AI Gift-Finder App That Replaces Guesswork With Personalized Picks in Seconds
  • Beverly.io Announces Nationwide Expansion and Poppins Payroll Partnership for Families
  • New Book: The Battle for Truth and Shadows - Guardians of Light - Epic Fantasy Unveils a War Between Light and Deception
  • Comfortable Clothing for Every Moment
  • Clash of Prompts: The World's First AI Prompt Battle Royale
  • $7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
  • MainConcept Announces Multiview Encoding for Apple Immersive Video
  • CCHR Rejects Global Psychiatric Push to Electroshock Children
  • iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
  • Americans Leave Behind or Discard 42% of Their Belongings When Moving Out for the First Time, Talker Research Finds
  • Central Florida Luxury Real Estate Firm DANHOLM COLLECTION Partners with Luxury Presence to Expand Global Buyer Reach
  • Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps
  • Charlotte Dad Builds AI Platform That Found $1.5M in Scholarships for His Family — Debt Free
  • InterMountain Management Announces the Re-opening of Holiday Inn Express & Suites Alexandria
  • New from Regal House Publishing, Gone Before You Knew Me, a biting YA about a girl who may disappear
  • Nufabrx Announces Strategic Acquisition of Elos Thermal
  • CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH
  • Contracting Resources Group Named to the 2026 Inc. Regionals: Mid-Atlantic List
  • Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports
  • Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
_catLbl0 _catLbl1

Popular on ncarol.com

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 357
  • Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets - 144
  • Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
  • Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
  • Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
  • UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value
  • Pacific Emblem Company Launches "Happy 250th Birthday America" Collection and Proud Supporter of the Gary Sinise Foundation
  • Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry

Similar on ncarol.com

  • The Hardest Part of Building an App Isn't Starting - It's Finishing
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • Go Dental Clinic Announces Upcoming Opening of New Branch in International City, Dubai
  • Contracting Resources Group and Aalis Management Consulting Launch ARG Joint Venture Under SBA Mentor-Protégé Program
  • EduCare Inc. Bridges Critical Gap in Breast Cancer Education with Spanish COPE Library Launch
  • Engineering leaders from industry, academia to gather at IISE Annual Conference & Expo in Arlington, Texas
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • BestDoc Launches AI Call Center for Healthcare
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • Dr. Rosendo Icochea, MD Recognized for Contributions to Surgical Education and Medical Research
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute